EAACI 2021
10/07/2021 -
12/07/2021
Krakow, Poland
Watch the content from our past Annual Congresses – re-discover talks that impressed you, or refresh your knowledge with lectures you did not have the chance to listen to before.
Filter
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
-
-
-
-
-
-
-
Presentation 06/12/2022
We are what we eat – importance of food to health, moving past simple calories
- Venter, C.
-
-
-
Presentation 06/12/2022
Using BAT for differentiation between sensitization and allergy to alpha-gal
- Eberlein, B.
-
-
-
Presentation 06/12/2022
Understanding immunological mechanisms that confer a higher risk of allergy
- Jiménez-Saiz, R.
-
-
-
Presentation 06/12/2022
Trained immunity and tolerance in innate lymphoid cells, monocytes, and dendritic cells during allergen-specific immunotherapy
- Eljaszewicz, A.
-
Presentation 06/12/2022
Time for innovation: what can we learn from OMICs about asthma metabolic dysfunction?
- Pite, H.
-
-
Presentation 06/12/2022
The trajectory of immune development in early life and its association with clinical allergic disease outcomes
- Gamez, C.
-
-
-
Presentation 06/12/2022
The concept of AllergoOncology: understanding the potential of IgE Antibodies in cancer
- Jensen-Jarolim, E.
-
-
-
-
Presentation 06/12/2022
Should blood eosinophils tresholds guide patient selection for anti-IL5 biologicals? (Pro&Con Session: Pro)
- Pavord, I.
-
Presentation 06/12/2022
Severe cutaneous allergic reactions: searching for the culprit drug
- Serrano, C.
-
Presentation 06/12/2022
Role of antigen-presenting cells in tolerance and allergy
- Benito Villalvilla, C.
-
-
Presentation 06/12/2022
Real-life evidence of the burden of chronic rhinosinusitis (CRS)
- Heffler, E.
-
Presentation 06/12/2022
Psychological support to peanut allergic children and their families
- Dunn Galvin, A.
-
Presentation 06/12/2022
Proteomic and biological analysis of human in vitro vascular smooth muscle cell system in response to anaphylaxis
- Yuste-Montalvo, A.
-
-
Presentation 06/12/2022
Prevention and therapy in primary immunodeficiencies: Vaccination
- Gennery, A.
-
-
Presentation 06/12/2022
Practical approach of diagnosis and management of not IgE mediated food allergies
- Eigenmann, P.
-
-
-
Presentation 06/12/2022
Personalized nutrition approach towards better QOL in Food Allergy
- Venter, C.
-
-
Presentation 06/12/2022
Pathogenic Th cell population disease induction model: – From the recruitment of eosinophils to the induction of fibrosis
- Hirahara, K.
-
-
Presentation 06/12/2022
ÖGAI: Covid as best practice model to combine immunology and allergy
- Jensen-Jarolim, E.
-
Presentation 06/12/2022
Non-steroidal anti-inflammatory drugs exacerbated disease (NERD)
- Mastalerz, L.
-
-
-
-
Presentation 06/12/2022
Molecular and structural considerations for aerosolization of food allergens
- Lopata, A.
-
-
-
06/12/2022
Metabolic changes in the prediction of severe anaphylactic reactions
- Villaseñor solis, A.
-
Presentation 06/12/2022
Mental health during the COVID-19 pandemic: how to cope with job stress and build resilience
- Dunn Galvin, A.
-
Presentation 06/12/2022
May contain traces… management in children with food allergies
- Eigenmann, P.
-
Presentation 06/12/2022
MAIT cells are imprinted by the microbiota in early life and promote tissue repair
- Constantinides, M.
-
-
Presentation 06/12/2022
Lessons learned from immune tolerance approaches to target allergic diseases: an NIAD’s perspective
- Togias, A.
-
Presentation 06/12/2022
Inhibiting Type 2 inflammation in atopic dermatitis with dupilumab modulates COVID-19 responses
- Guttman-Yassky, E.
-
Presentation 06/12/2022
Implementation of telehealth in asthma management: trials and tribulations
- Szefler, S.
-
Presentation 06/12/2022
Immune regulation in specific B cells in food allergy, tolerance and outgrowing children
- Akdis, M.
-
-
Presentation 06/12/2022
How to select and follow a biological for asthma and CRSwNP
- Pérez de Llano, L.
-
-
Presentation 06/12/2022
How to improve compliance of allergen immunotherapy in the clinic?
- Durham, S.
-
-
Presentation 06/12/2022
How does Type 2 mucosal inflammation influence susceptibility to SARS-CoV-2?
- Jackson, D.
-
-
Presentation 06/12/2022
Getting the diagnosis right is essential for optimal nutritional and dietary management of food allergy
- Skypala, I.J.
-
-
-
Presentation 06/12/2022
Flare-up phenomenon of Sars-CoV2 vaccine secondary to epicutaneous test with polyethylene glycol
- Torrado español, I.
-
Presentation 06/12/2022
Exposome modulation and immunotherapy in infants at higher risk of respiratory allergies
- Eguiluz-Gracia, I.
-
-
-
Presentation 06/12/2022
Entre US y Europa. La Experiencia de la Inmunoterapia en Mexico
- Larenas-linnemann, D.
-
-
-
Presentation 06/12/2022
Durable reduction in hereditary angioedema (HAE) attack rates with berotralstat over 24 months: results from the phase 3 apeX-2 study
- Kiani-alikhan, S.
-
-
-
-
-
-
-
Presentation 05/12/2022
COVID-19 Vaccination: Separating facts from fiction for your patients
- Moya, B.
-
-
Presentation 05/12/2022
COVID-19 and virus-induced asthma in children: Asian vs western perspectives
- Wang, J.
-
Presentation 05/12/2022
Contraindications to venom immunotherapy and risk factors for adverse events: any left?
- Sturm, G.
-
-
-
-
-
Presentation 05/12/2022
Biomarkers and predictors of responses to biologicals in atopic dermatitis
- Guttman-Yassky, E.
-
Presentation 05/12/2022
Beyond first line therapies for recalcitrant allergic diseases: Asthma
- Corbett, M.
-
-
Presentation 05/12/2022
Bacterial lysates in asthma treatment in children / Lizaty bakteryjne w astmie u dzieci.
- Emeryk, A.
-
-
Presentation 05/12/2022
Asthma endotypes as risk factors for severe COVID-19 manifestations
- Johnston, S.
-
-
-
-
-
Presentation 05/12/2022
Allergen immunotherapy has a role in the era of biologics (Con&Pro Session: Con)
- Barber, D.
-
Presentation 05/12/2022
Alergia molecular na seleção de extratos para imunoterapia aos ácaros
- Barber, D.
-
-
-
Abstract Book 08/11/2022Allergy School Cork 2022 Abstract Book
-
Presentation 02/12/2021
Allergic severe asthma and cat epithelia in COVID-19 pandemic: a case report
- Galvan Blasco, P.
-
-
Presentation 03/11/2021
Prescribing immunotherapy to pollens in children: influence of geographical and sociological diversity
- Barber, D.
-
Presentation 03/11/2021
Does pediatric asthma primarily depend on submicrone aerosol pollutants?
- Juskiene, I.
-
Presentation 03/11/2021
Weak correlation between percentage of predicted values of PEF and FEV1 parameters in children population
- Solinski, M.
-
Presentation 03/11/2021
The role of EGR-1 as a potential biomarker in asthma and proinflammatory responses in airway epithelium
- Van Dijk, Y.
-
-
-
-
Presentation 03/11/2021
Why is a transition clinic needed for adolescents and young adults (AYA) with allergy and asthma?
- Vazquez-Ortiz, M.
-
Presentation 03/11/2021
New visions for managing anaphylaxis. Lesson from EAACI guidelines
- Muraro, A.
-
-
Presentation 03/11/2021
Ligelizumab in adolescent patients with chronic spontaneous urticaria: results from a dedicated phase 2b study
- Alvaro-Lozano, M.
-
Presentation 03/11/2021
Trichinella spiralis infection associated with chronic spontaneous urticaria – case series
- Ogneva, D.
-
Presentation 03/11/2021
Paediatric multisystem allergy: a new diagnostic and severity score
- Gainsborough, F.
-
Presentation 03/11/2021
Oral food challenge versus biomarkers – are challenges still needed?
- Beyer, K.
-
Presentation 03/11/2021
How can we improve the quality of life of patients with severe food allergy?
- DunnGalvin, A.
-
Presentation 03/11/2021
Can we identify patients at risk of life-threatening allergic reaction to food?
- Gupta, R.
-
Presentation 03/11/2021
Cow’s milk protein-induced allergic proctocolitis: cohort review
- González germán, M.
-
Presentation 03/11/2021
The clinical burden of cow’s milk allergy in childhood – a retrospective cohort study
- Sorensen, K.
-
Presentation 03/11/2021
Mental health needs and access to care among patients with food allergy
- Knibb, R.
-
-
-
-
-
Presentation 03/11/2021
How to classify cutaneous manifestations of drug hypersensitivity
- Brockow, K.
-
Presentation 03/11/2021
When to evaluate children with atopic dermatitis for Type IV allergy
- Pasmans, S.
-
-
Presentation 03/11/2021
Does human milk and its composition matter for development and prevention of allergies?
- Verhasselt, V.
-
-
-
-
Presentation 01/07/2021
Biological severe asthma treatment in Poland – pros and cons of drug programme
- Kucharczyk, A.
-
Presentation 01/07/2021
Diagnosis and allocation to biologics in severe asthma – guidelines of the Polish Society of Allergology
- Kupczyk, M.
-
-
-
-
-
-
-
-
Presentation 01/07/2021
Benralizumab in severe eosinophilic asthma… Or is it something else?
- Gomes, J.
-
Presentation 02/03/2021
When to suspect allergic contact dermatitis in atopic dermatitis patients
- Rustemeyer, T.
-
-
Presentation 02/03/2021
Mechanism and prevention of epicutaneous sensitization to food allergens
- Brough, H.A.
-
-
Presentation 02/03/2021
Is There A Place For Chlorhexidine In The European Baseline Series?
- Calado, R.
-
Presentation 02/03/2021
Is Patch Testing Valuable In Orofacial Granulomatosis/Granulomatous Cheilitis?
- Calvão, J.
-
-
-
Presentation 19/06/2020
Ligelizumab achieves high rate of complete response in patients with moderate to severe chronic spontaneous urticaria
- Bernstein, J.
-
Presentation 19/06/2020
Genetic polymorphisms of CD14 and TLR-4 and utility of probiotic therapy in adults with atopic dermatitis
- Bisyuk, Y.
-
-
-
-
-
Presentation 19/06/2020
Precision medicine and biomarkers in chronic rhinosinusitis with nasal polyps
- Zhang, L.
-
-
-
Presentation 19/06/2020
Understanding parent preferences for paediatric allergy services
- Diwakar, L.
-
-
Presentation 19/06/2020
The effect of tezepelumab in patients with allergic asthma: Results from the PATHWAY phase IIb study
- Corren, J.
-
Presentation 19/06/2020
Efficacy and safety of masitinib in severe asthma: Eosinophilic subgroup analysis from study AB07015
- Davidescu, L.
-
Presentation 19/06/2020
Food diversity during the first year and risk of atopic eczema and food allergy up to 12 years of age
- Nwaru, B.
-
Presentation 19/06/2020
Development of a childhood asthma prediction model using machine learning approaches
- Kothalawala, D.
-
Presentation 19/06/2020
Benralizumab efficacy for severe, eosinophilic asthma with a diagnosis of nasal polyposis: Results from the phase IIIb ANDHI trial
- Canonica, G.W.
-
-
-
-
Presentation 19/06/2020
Indoor air quality in primary schools is associated with atopic sensitization, airway inflammation and FEV1 reversibility in schoolchildren
- Cavaleiro Rufo, J.
-
-
Presentation 19/06/2020
Can the birch pollen be more aggressive in the polluted environments?
- Myszkowska, D.
-
Presentation 19/06/2020
Healthcare use and asthma control among overweight/obese urban children sensitized and exposed to classroom allergens
- Permaul, P.
-
Presentation 19/06/2020
Air pollution-induced augmented allergenicity of Platanus hybrida pollen in urban environments
- Antunes, C.
-
-
Presentation 19/06/2020
Does probiotic microorganism lactobacillus reuteri prevents allergic rhinitis and rhinoconjunctivitis development in children
- Besednjak-Kocijancic, L.
-
-
-
-
Presentation 19/06/2020
Moderate-to-severe asthma in individuals of European ancestry: a genome-wide association study
- Portelli, M.
-
Presentation 19/06/2020
Novel therapeutic approaches targeting endotypes of severe airway disease
- Gevaert, P.
-
Presentation 19/06/2020
Interferon therapy in airway disease: prophylaxis is the new approach in exacerbation prevention?
- Johnston, S.
-
-